Kohlruss, Meike
Chakraborty, Shounak
Hapfelmeier, Alexander
Jesinghaus, Moritz
Slotta-Huspenina, Julia
Novotny, Alexander
Sisic, Leila
Gaida, Matthias M.
Ott, Katja
Weichert, Wilko
Pfarr, Nicole
Keller, Gisela http://orcid.org/0000-0003-2886-0371
Funding for this research was provided by:
Wilhelm Sander (2019.156.1)
Technische Universität München
Article History
Received: 15 August 2023
Accepted: 13 September 2023
First Online: 11 October 2023
Change Date: 17 November 2023
Change Type: Update
Change Details: The Original article is updated to include the supplement files.
Declarations
:
: WW has attended advisory boards and served as a speaker for Roche, MSD, BMS, AstraZeneca, Pfizer, Merck, Lilly, Boehringer, Novartis, Takeda, Bayer, Amgen, Astellas, Eisai, Johnson & Johnson, Janssen, Illumina, Siemens, Agilent, ADC, GSK, and Molecular Health. WW received research funding from Roche, MSD, BMS, and AstraZeneca. NP has attended advisory boards of Novartis, Bayer, Lilly, Roche, AstraZeneca. NP received speaker fees from Illumina, Thermo Fisher Scientific, Roche, BMS, AstraZeneca, Bayer, MSD, QuiP and received travelling support from BMS, Illumina, Thermo Fisher Scientific, PGDx. The other authors declare no conflicts of interest.